BioSpace News Archive

Quantabio , a leading provider of robust DNA and RNA amplification reagents for the most demanding molecular testing and life science research applications, today announced a new optimized Bead Booster chemistry for its sparQ RNA-Seq HMR Kit, an ultra-fast RNA next-generation sequencing (NGS) library preparation tool with ribosomal RNA (rRNA) and globin mRNA depletion.

Waters Corporation introduced Alliance iS, the next-generation intelligent HPLC System, designed to reduce compliance risk by adding new levels of proactive error detection, troubleshooting and ease-of-use.

The new PerkinElmer business acquired by New Mountain Capital announced today the appointment of Dirk Bontridder as Chief Executive Officer effective March 13, 2023.

Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, today announced that it will release financial results for the fourth quarter and full year of 2022 after the close of trading on Thursday, March 30, 2023.

Surgalign Holdings, Inc. today announced the first major upgrade of the HOLO Portal™ Surgical Guidance System since the first case was performed in May of 2022.

SurgVision, a high-tech company developing pioneering solutions for fluorescence-guided surgical and interventional oncology, part of the Bracco Group, announces that it has received 510(k) clearance from the U.S. Food and Drug Administration for the EXPLORER AIR® II for use with Pafolacianine (CYTALUX, On Target Laboratories Inc.) during intraoperative fluorescence imaging.

Quest Diagnostics (NYSE: DGX), the nation’s leading provider of diagnostic information services, today announced it has completed its previously announced acquisition of select assets of Northern Light Laboratory, the outreach laboratory services business of Northern Light Health, a large integrated healthcare system in Maine.

Dr. Raphael Kellman, MD is successfully treating autoimmune diseases through Cellular Therapy, an innovative and cutting-edge therapy using the body’s own cells.

MatriSys BioScience today announced that its scientific co-founder, Dr. Richard Gallo , received the Eugene J Van Scott award for Innovative Therapy of the Skin from the American Academy of Dermatology (AAD).

Lunit (KRX:328130.KQ) today announced that its AI solution for 3D Breast Tomosynthesis (DBT) analysis, Lunit INSIGHT DBT, has met the requirements of the CE marking under Europe’s latest Medical Device Regulation (MDR).